XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Revenue $ 1,176,096,000 $ 210,118,000
Operating expenses:    
Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets 12,862,000 14,740,000
Amortization of acquired intangible assets 3,798,000 51,530,000
Research and development 108,973,000 116,129,000
Selling, general and administrative 80,961,000 73,272,000
Change in the fair value of contingent consideration (800,000) (100,000)
Tangible asset impairment and losses on transactions, net 77,000  
Total operating expenses 205,871,000 255,571,000
Income (loss) from operations 970,225,000 (45,453,000)
Interest expense, net (34,092,000) (40,834,000)
Other (expense) income, net (6,305,000) 1,591,000
Income (loss) before income tax expense 929,828,000 (84,696,000)
Income tax expense (63,266,000) (6,880,000)
Net income (loss) attributable to common stockholders $ 866,562,000 $ (91,576,000)
Weighted-average shares outstanding:    
Basic 78,115,836 76,496,127
Diluted 86,385,922 76,496,127
Net income (loss) per share-basic and diluted (in dollars per share)    
Basic $ 11.09 $ (1.2)
Diluted $ 10.04 $ (1.2)
Net product revenue    
Revenues:    
Revenue $ 153,426,000 $ 177,604,000
Collaboration and license revenue    
Revenues:    
Revenue 986,231,000  
Royalty revenue    
Revenues:    
Revenue 36,439,000 31,154,000
Manufacturing revenue    
Revenues:    
Revenue $ 0 $ 1,360,000